Skip to main content

Table 2 Outcomes after one year by sarcopenia status

From: Does sarcopenia predict change in mobility after hip fracture? a multicenter observational study with one-year follow-up

 

Marginal values

Regression (sarcopenic – not sarcopenic)

 

Not sarcopenic

Sarcopenic

Unadjusted

Adjusted

 

Mean

(SD)

No.

Mean

(SD)

No.

Estimate

95% CI

P

Estimate

95% CI

P

Change NMS

−1.2

(1.8)

n = 117

−1.3

(1.9)

n = 67

0.0

−0.6 to 0.6

0.9

0.2

−0.5 to 0.9

0.6

Change B-ADL

−0.8

(2.4)

n = 76

−2.2

(3.9)

n = 52

−0.4

−1.2 to 0.3

0.3

−0.3

− 1.1 to 0.6

0.6

 

Not Sarcopenic

Sarcopenic

OR

95% CI

P

Fracture, n (%) N

7

(6)

n = 120

8

(11)

n = 71

2.0

(0.6 to 7.0)

0.3

Hip fractures, n (%) N

3

(2)

n = 124

3

(4)

n = 77

1.6

(0.2 to 12.5)

0.7

Reoperations, n (%) N

7

(6)

n = 124

1

(1)

n = 77

0.2

(0.0 to 1.8)

0.2

Hospitalization, n (%) N

41

(33)

n = 123

24

(33)

n = 73

1.0

(0.5 to 1.9)

1.0

Nursing home, n (%) N

5

(4)

n = 124

9

(12)

n = 77

3.2

(0.9 to 12.4)

0.048

Death, n (%) N

3

(2)

n = 124

5

(6)

n = 77

2.8

(0.5 to 18.5)

0.3

Death or nursing home, n (%) N

6

(5)

n = 124

12

(16)

n = 77

3.6

(1.2 to 12.3)

0.02

  1. Outcomes after one year by sarcopenia status (sarcopenic – not sarcopenic). Regression analysis for change in mobility and Barthel ADL from pre-fracture until one year adjusted for age, sex and BMI with imputation of missing values. ADL: Barthel Activities of daily living. Analysis for fracture, hip fracture, reoperations, all-cause hospitalization, nursing home, death or nursing home or death by two-sided Fisher’s exact test using available cases. NMS: New mobility score. B-ADL: Barthel activities of daily living. OR: Odds ratio